Diagnosing, treating and monitoring the inflammatory endotype in osteoarthritis clinical trials

  • 0Immunoscience, Nordic Bioscience, Herlev, Denmark.

|

|

Summary

This summary is machine-generated.

Osteoarthritis (OA) has an inflammatory component. Identifying patients with this inflammatory subtype may improve treatment outcomes and clinical trial design for targeted therapies.

Area Of Science

  • Rheumatology
  • Immunology
  • Molecular Biology

Background

  • Osteoarthritis (OA) is characterized by inflammation, including synovitis and low-grade systemic inflammation.
  • Anti-inflammatory treatments show potential for symptomatic and structural benefits in OA.
  • Identifying patients with an inflammatory OA subtype is crucial for targeted therapy.

Purpose Of The Study

  • To review evidence for a clinically actionable inflammatory molecular endotype of OA.
  • To outline tools for single-patient endotyping.
  • To discuss practical considerations for recognizing inflammatory OA in clinical trials.

Main Methods

  • Integration of recent clinical studies.
  • Analysis of biomarker consortium datasets.
  • Review of imaging models for OA assessment.

Main Results

  • Emerging evidence supports distinct inflammatory OA endotypes.
  • Patients with elevated cytokines (IL-1, TNF-α), synovitis, or specific biomarkers may respond better to anti-inflammatories.
  • Tools for endotyping are being developed but require standardization.

Conclusions

  • Standardizing tools for identifying inflammatory OA patients is a key challenge.
  • Current diagnostic methods (imaging, biomarkers) are not yet standard clinical practice.
  • Understanding the inflammatory endotype is vital for optimizing clinical trials and patient stratification.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests 01:27

38

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy 01:30

419

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Clinical Trials: Overview 01:11

3.4K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies 01:22

57

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Inflammatory Bowel Disease IV: Pharmacological Management 01:29

189

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Clinical Trials 01:16

8.1K

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...